[Undifferentiated carcinoma of the thyroid gland].
Undifferentiated carcinoma of the thyroid gland: sonographic findings.
[Undifferentiated carcinoma and lymphoma of the thyroid gland. Apropos of a series of 38 cases].
CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment.
Pan Z, Xu T, Bao L, Hu X, Jin T, Chen J, Chen J, Qian Y, Lu X, Li L, Zheng G, Zhang Y, Zou X, Song F, Zheng C, Jiang L, Wang J, Tan Z, Huang P, Ge M.
Mol Cancer. 2022 Oct 3;21(1):190. doi: 10.1186/s12943-022-01658-x.
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.
Zeng PYF, Prokopec SD, Lai SY, Pinto N, Chan-Seng-Yue MA, Clifton-Bligh R, Williams MD, Howlett CJ, Plantinga P, Cecchini MJ, Lam AK, Siddiqui I, Wang J, Sun RX, Watson JD, Korah R, Carling T, Agrawal N, Cipriani N, Ball D, Nelkin B, Rooper LM, Bishop JA, Garnis C, Berean K, Nicolson NG, Weinberger P, Henderson YC, Lalansingh CM, Tian M, Yamaguchi TN, Livingstone J, Salcedo A, Patel K, Vizeacoumar F, Datti A, Xi L, Nikiforov YE, Smallridge R, Copland JA, Marlow LA, Hyrcza MD, Delbridge L, Sidhu S, Sywak M, Robinson B, Fung K, Ghasemi F, Kwan K, MacNeil SD, Mendez A, Palma DA, Khan MI, Shaikh M, Ruicci KM, Wehrli B, Winquist E, Yoo J, Mymryk JS, Rocco JW, Wheeler D, Scherer S, Giordano TJ, Barrett JW, Faquin WC, Gill AJ, Clayman G, Boutros PC, Nichols AC.
Cell Rep. 2024 Mar 26;43(3):113826. doi: 10.1016/j.celrep.2024.113826. Epub 2024 Feb 26.
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H, Goldner WS, Guo T, Haymart M, Holt S, Hunt JP, Iagaru A, Kandeel F, Lamonica DM, Mandel S, Markovina S, McIver B, Raeburn CD, Rezaee R, Ridge JA, Roth MY, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Yeh M, Cassara CJ, Darlow S.
J Natl Compr Canc Netw. 2022 Aug;20(8):925-951. doi: 10.6004/jnccn.2022.0040.
Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
Xu B, Fuchs T, Dogan S, Landa I, Katabi N, Fagin JA, Tuttle RM, Sherman E, Gill AJ, Ghossein R.
Thyroid. 2020 Oct;30(10):1505-1517. doi: 10.1089/thy.2020.0086. Epub 2020 May 8.
ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma.
Xu T, Zhu C, Chen J, Song F, Ren X, Wang S, Yi X, Zhang Y, Zhang W, Hu Q, Qin H, Liu Y, Zhang S, Tan Z, Pan Z, Huang P, Ge M.
J Exp Clin Cancer Res. 2023 Jul 27;42(1):182. doi: 10.1186/s13046-023-02751-9.
Anaplastic Transformation of Differentiated Thyroid Carcinoma.
Yu AC, Han AY, Cronkite DA, Sajed D, St John MA.
Laryngoscope. 2023 Feb;133(2):437-442. doi: 10.1002/lary.30277. Epub 2022 Jul 2.
Molecular Biomarkers of Anaplastic Thyroid Carcinoma.
Bozorg-Ghalati F, Hedayati M.
Curr Mol Med. 2017;17(3):181-188. doi: 10.2174/1566524017666170822102417.
Imaging of Anaplastic Thyroid Carcinoma.
Ahmed S, Ghazarian MP, Cabanillas ME, Zafereo ME, Williams MD, Vu T, Schomer DF, Debnam JM.
AJNR Am J Neuroradiol. 2018 Mar;39(3):547-551. doi: 10.3174/ajnr.A5487. Epub 2017 Dec 14.
Quelles avancées dans la prise en charge du carcinome anaplasique de la thyroïde en 2024 ?
Jannin A, Lugat A, Escande A, Godbert Y, Wasserman J, Do Cao C, Hadoux J.
Bull Cancer. 2024 Oct;111(10 Suppl 1):10S42-10S52. doi: 10.1016/S0007-4551(24)00407-7.
SATB2 is an Emergent Biomarker of Anaplastic Thyroid Carcinoma: A Series with Comprehensive Biomarker and Molecular Studies.
Nkosi D, Crowe WE, Altman BJ, Oltvai ZN, Giampoli EJ, Velez MJ.
Endocr Pathol. 2024 Dec;35(4):432-441. doi: 10.1007/s12022-024-09833-0. Epub 2024 Nov 5.
